Company · CIK 1581987
TiGenix NV
Source: SEC EDGAR · as of 2026-10-27 06:30 UTC · latest filing day 2026-10-26
| CIK | 1581987 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | C9 |
| Business address | Belgium |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2017-04-06 |
Offerings
1 registration| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-208693 | 2015-12-22 | 2016-12-15 | 11 |
Filings
13| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2016-12-15 | 424B4Final prospectus | 333-208693 | 0001047469-16-017214 |
| 2016-12-14 | EFFECTDeclared effective | 333-208703 | 9999999995-16-006446 |
| 2016-12-14 | EFFECTDeclared effective | 333-208693 | 9999999995-16-006445 |
| 2016-12-14 | F-1/AAmendment | 333-208693 | 0001047469-16-017184 |
| 2016-12-05 | F-1/AAmendment | 333-208693 | 0001047469-16-017053 |
| 2016-11-29 | F-1/AAmendment | 333-208693 | 0001047469-16-016983 |
| 2016-10-26 | F-1/AAmendment | 333-208693 | 0001047469-16-016310 |
| 2016-07-13 | F-1/AAmendment | 333-208693 | 0001047469-16-014300 |
| 2016-07-06 | F-1/AAmendment | 333-208693 | 0001047469-16-014179 |
| 2016-05-13 | F-1/AAmendment | 333-208693 | 0001047469-16-013153 |
| 2016-02-03 | F-1/AAmendment | 333-208693 | 0001047469-16-009998 |
| 2015-12-22 | F-1Registration filed | 333-208693 | 0001047469-15-009374 |
| 2014-10-03 | DRSDraft made public | 377-00807 | 0000912057-14-000406 |